| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |